中國醫藥大學 |
2007-04-14 |
Down-regulation of HER2 by IFN-gamma-induced RIG1 followed by PI3K/Akt/mTOR/VEGF pathway in ovarian cancer cells
|
(Chien-Chih Ou); (Shih-Chung Hsu); (Yin-Hui Hsieh); (Won-Ling Tzou); (Jia-Yaw Liu); 高銘欽(Ming-Ching Kao)* |
中國醫藥大學 |
2007-03-17 |
A proteomics approach to the molecular mechanism of tumor inhibition by Ganoderma tsugae extracts in human ovarian cancer SKOV-3 cells
|
(Wang YC); (Hsu SC); (Kuo HP); (Tzou WL); (Yeh MH); (Lin YH); (Chen CS); 高銘欽(Ming-Ching Kao)* |
中國醫藥大學 |
2007-03 |
ROS Mediates Baicalin-induced Apoptosis in Human Promyelocytic Leukemia HL-60 Cells through the Expression of the GADD153 and Mitochondria-dependent Pathway.
|
(Lu H. F.); (Hsueh S. C.); (Ho Y. T.,); 高銘欽(Ming-Ching Kao); 楊家欣; (Chiu T. T.,); (Huang S. Y.,); (Lin C. C.); 鍾景光* |
中國醫藥大學 |
2006-10 |
Antizyme, a natural ornithine decarboxylase inhibitor, induces apoptosis of haematopoietic cells through mitochondrial membrane depolarization and caspases' cascade
|
(Liu GY); (Liao YF); (Hsu PC); (Chang WH); (Hsieh MC); (Lin CY); (Hour TC); 高銘欽(Ming-Ching Kao); (Tsay GJ); (Hung HC)* |
中國醫藥大學 |
2006-07-31 |
評估胞質型神經膠原致癌蛋白在國人大腸直腸癌腫瘤中之角色
|
高銘欽(Ming-Ching Kao); 許來發(Lai-Fa Hsu) |
中國醫藥大學 |
2006-07-19 |
supression of colorectal tumor growth by Ganoderma tsugae extract causes G2/M arrest
|
高銘欽(Ming-Ching Kao)*; 許世忠(Shih-Chung Hsu); 王文奇(Vinchi Wang); 莊子超(Tzu-Chao Chuang); 劉嘉燿(Jia-Yaw Liu); 陳精祥(Chin-Shiung Chen); 林松洲(Sun-Chow Lin) |
中國醫藥大學 |
2006-03 |
Increasing ornithine decarboxylase activity is another way of prolactin preventing methotrexate-induced apoptosis: crosstalk between ODC and BCL-2
|
(Hsu PC); (Hour TC); (Liao YF); (Hung YC); (Liu CC); (Chang WH); 高銘欽(Ming-Ching Kao); (Tsay GJ); (Hung HC); (Liu GY)* |
中國醫藥大學 |
2006-01 |
Gene Transfer Mediated by Sphingosine/Dioleoylphosphatidylethanolamine Liposomes in the Presence of Poloxamer 188
|
(Law SL); (Chuang TC); 高銘欽(Ming-Ching Kao); (Lin YS); (Huang KJ) |
中國醫藥大學 |
2005-12-31 |
臺灣栽培靈芝在血管增生抑制效能上之癌症治療研究
|
高銘欽(Ming-Ching Kao) |
中國醫藥大學 |
2005-08 |
Ornithine decarboxylase prevents methotrexate-induced apoptosis by reducing intracellular reactive oxygen species production
|
(Huang CC); (Hsu PC); (Hung YC); (Liao YF); (Liu CC); (Hour CT); 高銘欽(Ming-Ching Kao); (Tsay GJ); (Hung HC); (Liu GY)* |
中國醫藥大學 |
2005-07-31 |
卵巢癌基因治療--微脂粒媒介病毒核抗原抑制卵巢癌患者癌細胞生長之動物試驗
|
劉嘉燿(Jha-Yao Liu); 高銘欽(Ming-Ching Kao) |
中國醫藥大學 |
2005-07-31 |
Gene chip approach to the molecular mechanism of repression of HER2/neu by the N-terminal domain of SV40 large T antigen
|
高銘欽(Ming-Ching Kao); 姜淑媛(Su-Yuan Jiang) |
中國醫藥大學 |
2005-07 |
Nitric oxide induces prion protein via MEK and p38 MAPK signaling
|
(Wang V); (Chuang TC); (Hsu YD); (Chou WY); 高銘欽(Ming-Ching Kao)* |
中國醫藥大學 |
2005-04-16 |
Human MnSOD suppresses HER2/neu-mediated breast cancer malignancy
|
高銘欽(Ming-Ching Kao)*; 莊子超(Tzu-Chao Chuang); 湯雅婷(Ya-Ting Tan); 林彥杏(Yeng-Shing Lin); 劉嘉燿(Jia-Yaw Liu); 林棋財(Chi-Tsai Lin) |
中國醫藥大學 |
2005-04 |
Clinicopathological relevance of HER2/neu and a related gene-protein cubic regression correlation in colorectal adenocarcinomas in Taiwan
|
(Li JW); (Chuang TC); (Yang AH); (Hsu CK); 高銘欽(Ming-Ching Kao)* |
中國醫藥大學 |
2005-02 |
Skeletal muscle dihydropyridine-sensitive calcium channel (CACNA1S) gene mutations in chinese patients with hypokalemic periodic paralysis
|
(Lin SH)*; (Hsu YD); (Cheng NL); 高銘欽(Ming-Ching Kao) |
中國醫藥大學 |
2005-01 |
Degradation of HER2/neu by apigenin induces apoptosis through cytochrome c release and caspase-3 activation in HER2/neu-overexpressing breast cancer cells
|
魏宗德; 高銘欽(Ming-Ching Kao); (Lin JK*)* |
中國醫藥大學 |
2004-12-31 |
台灣本土栽培靈芝在抗癌保健作用的效益評估
|
高銘欽(Ming-Ching Kao) |
中國醫藥大學 |
2004-11-09 |
Oncogene-targeting cancer gene therapy
|
高銘欽(Ming-Ching Kao)* |
中國醫藥大學 |
2004-09 |
Black tea polyphenol theaflavins inhibit aromatase activity and attenuate tamoxifen resistance in HER2/neu-transfected human breast cancer cells through tyrosine kinase suppression.
|
魏宗德; (Lee HH); 高銘欽(Ming-Ching Kao); (Lin JK*)* |
中國醫藥大學 |
2004-07-31 |
Gene chip approach to the molecular mechanism of repression of HER2/neu by the Epstein-Barr virus nuclear antigen-1
|
高銘欽(Ming-Ching Kao) |
中國醫藥大學 |
2004-06-12 |
Suppression of HER2/neu by superoxide dismutase in breast cancer MDA-MB-453 cells
|
高銘欽(Ming-Ching Kao)*; 莊子超(Tzu-Chao Chuang); 湯(Ya-Ting Tan); 林(Yeng-Shing Lin); 林棋財(Chi-Tsai Lin) |
中國醫藥大學 |
2004-02 |
Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway
|
魏宗德(Tzong-Der Way); 高銘欽(Ming-Ching Kao); 林仁混(Lin JK)* |
中國醫藥大學 |
2003-11-07 |
The N-terminal domain only of EBNA1 as a tumor suppressor
|
高銘欽(Ming-Ching Kao)*; 莊子超(Tzu-Chao Chuang); 胡誌麟(Chih-Lin Hu); 林彥杏(Yeng-Shing Lin); 劉嘉燿(Jia-Yaw Liu); 羅世農(Sai-Lung Law) |
中國醫藥大學 |
2003-08 |
EBNA1 may prolong G2/M phase and sensitize HER2/neu-overexpressing ovarian cancer cells to both topoisomerase II-targeting and paclitaxel drugs
|
(Chuang TC); (Lee YJ); (Liu JY); (Lin YS); (Lee JW); (Wang V); (Law SL); 高銘欽(Ming-Ching Kao)* |